SCHEMBL4338073

SCHEMBL4338073

COc1ccc(CC(C(=O)O)C(=O)O)cc1COC(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.51
CNR1 P21554 2/20 0.48
GAA P10253 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP3A4 P08684 1/20 0.47
PPARA Q07869 3/20 0.46
PPARG P37231 1/20 0.46
PPARD Q03181 1/20 0.46
TP53 P04637 1/20 0.45
POLB P06746 1/20 0.45
HPGD P15428 1/20 0.45
ATM Q13315 1/20 0.44
FPR2 P25090 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13810387 0.94 CNR1 (0.48) LDHACNR1GAASMN1; SMN2KMT2A
SCHEMBL4340268 0.90 LDHA (0.52) LDHAGAASMN1; SMN2KMT2AMEN1
SCHEMBL4334358 0.90 LDHA (0.52) LDHASMN1; SMN2KMT2ACYP1A2CYP2D6
SCHEMBL4340426 0.90 LDHA (0.54) LDHASMN1; SMN2KMT2APPARAPPARG
SCHEMBL4339592 0.89 KDM4E (0.46) LDHACNR1GAASMN1; SMN2KMT2A
SCHEMBL4329956 0.89 CNR1 (0.49) LDHACNR1SMN1; SMN2KMT2AMEN1
SCHEMBL4337170 0.88 MMP1 (0.44) CNR1GAASMN1; SMN2KMT2AMEN1
SCHEMBL4334763 0.86 PPARA (0.61) LDHAPPARAPPARGPPARD
SCHEMBL4336515 0.86 LDHA (0.48) LDHAGAASMN1; SMN2KMT2AMEN1
SCHEMBL13810383 0.84 NPSR1 (0.47) LDHAGAASMN1; SMN2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 LDHA 745/4885CNR1 75/4885GAA 2303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.